Mme Docteur EMILIE RICARD
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Activité de recherche & publications
Source : bases de données publiques (OpenAlex, PubMed).
h-index
2
h articles cités ≥ h fois chacun. Un h de 2 = 2 publications avec 2+ citations.
Citations
16
Publications
6
i10-index
1
Thématiques principales
- Rheumatoid Arthritis Research and Therapies ×2
- Biosimilars and Bioanalytical Methods ×2
- Hereditary Neurological Disorders ×2
- Whipple's Disease and Interleukins ×2
- Monoclonal and Polyclonal Antibodies Research ×1
Affiliations FR : Centre hospitalier universitaire d'Orléans
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Bibliographie
Stable efficacy and safety after switching from intravenous to subcutaneous tocilizumab in a cohort of 200 patients in real life conditions
2022ArticleJoint Bone Spine
Usefulness of polymerase chain reaction for diagnosing Whipple’s disease in rheumatology
2018ArticlePLoS ONE
Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients
2015ArticleRheumatology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Localisation
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
CABINET DU DR EMILIE RICARD
RESIDENCE VAL DE LOIRE - BATIMENT 9 — 9 RUE LE MOYNE DE BIENVILLE, 45100 Orléans
☎ 0238664012Libéral© OpenStreetMapCHRU ORLEANS - HOPITAL DE LA SOURCE
14 Avenue DE L'HOPITAL, 45067 Orléans
☎ 0238514444Hospitalier
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Top publications · les plus citées
- 1Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients
Rheumatology (Oxford, England) · 2015
- 3CMT4D (NDRG1 mutation): genotype-phenotype correlations
Journal of the peripheral nervous system : JPNS · 2013
📚 12 citationsLire l'abstract Crossref ↓
AbstractCharcot‐Marie‐Tooth (CMT) disease is a heterogeneous condition with a large number of clinical, electrophysiological and pathological phenotypes. More than 40 genes are involved. We report a child of gypsy origin with an autosomal recessive demyelinating phenotype. Clinical data, familial history, and electrophysiological studies were in favor of a CMT4 sub‐type. The characteristic N‐Myc downstream‐regulated gene 1 (NDRG1) mutation responsible for this CMT4D phenotype was confirmed: p.R148X. The exact molecular function of the NDRG1 protein has yet to be elucidated.
Publications scientifiques (6) — classées par pathologie
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Transversal5
▼
Transversal5
▼- Cervical Dysplasia and Treatments Barrier in Jail: A Study in Marseille's Detention Center-Les Baumettes, France
Women's health reports (New Rochelle, N.Y.) · 2022 · Journal Article
Delage de Luget C, Jauffret C, Faust C, Knight S, et al.
📚 3 cit. - Usefulness of polymerase chain reaction for diagnosing Whipple's disease in rheumatology
PloS one · 2018 · Journal Article
Herbette M, Cren JB, Joffres L, Lucas C, et al.
📚 13 cit.🩺 Clinique - Reasons for non-vaccination in French rheumatoid arthritis and spondyloarthritis patients
Rheumatology (Oxford, England) · 2015 · Letter
Hua C, Morel J, Ardouin E, Ricard E, et al.
📚 34 cit.🎯 RCR 1.52🔬→🩺 Translationnel - [Kingella Kingae sternoclavicular septic arthritis in an adult]
Medecine et maladies infectieuses · 2014 · Case Reports
Ricard E, Martin C, Bertin P, Denes E
📚 6 cit. - CMT4D (NDRG1 mutation): genotype-phenotype correlations
Journal of the peripheral nervous system : JPNS · 2013 · Case Reports
Ricard E, Mathis S, Magdelaine C, Delisle MB, et al.
📚 12 cit.
Biothérapies non-anti-TNF1
▼
Biothérapies non-anti-TNF1
▼- Stable efficacy and safety after switching from intravenous to subcutaneous tocilizumab in a cohort of 200 patients in real life conditions
Joint bone spine · 2022 · Letter
Larid G, Joffres L, Ricard E, Pereira Gillion C, et al.
📚 2 cit.